Production (Stage)
Atara Biotherapeutics, Inc.
ATRA
$7.80
$0.3054.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -70.07% | -17.84% | -34.39% | -77.03% | -77.49% |
| Total Receivables | -75.37% | -95.65% | 137.12% | 167.03% | 3,184.78% |
| Inventory | -- | 9.78% | 112.11% | 138.51% | 201.20% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -44.71% | 62.10% | 2.38% | -39.99% | -34.54% |
| Total Current Assets | -74.46% | -36.30% | -22.61% | -63.78% | -52.52% |
|
|
|||||
| Total Current Assets | -74.46% | -36.30% | -22.61% | -63.78% | -52.52% |
| Net Property, Plant & Equipment | -41.76% | -30.09% | -25.56% | -24.10% | -22.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.47% | -35.94% | -46.62% | -45.11% | -43.99% |
| Total Assets | -62.46% | -34.08% | -24.41% | -52.41% | -45.29% |
|
|
|||||
| Total Accounts Payable | -51.51% | 18.54% | -67.04% | 26.95% | -43.69% |
| Total Accrued Expenses | -59.14% | -56.32% | -52.11% | -52.91% | 0.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.83% | 14.27% | 10.24% | 8.07% | 11.28% |
| Total Finance Division Other Current Liabilities | -87.02% | 22.17% | 902.02% | 800.34% | 1,140.97% |
| Total Other Current Liabilities | -87.02% | 22.17% | 902.02% | 800.34% | 1,140.97% |
| Total Current Liabilities | -73.49% | -5.38% | 97.22% | 98.88% | 166.21% |
|
|
|||||
| Total Current Liabilities | -73.49% | -5.38% | 97.22% | 98.88% | 166.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.58% | -31.03% | -27.35% | -25.22% | -23.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.23% | -47.55% | -62.49% | -63.45% | -64.41% |
| Total Liabilities | -55.57% | -22.04% | -2.66% | -4.53% | 11.16% |
|
|
|||||
| Common Stock & APIC | 3.09% | 4.66% | 5.00% | 3.35% | 3.74% |
| Retained Earnings | -0.78% | -4.34% | -6.98% | -9.85% | -13.19% |
| Treasury Stock & Other | -- | 103.92% | 103.85% | 98.50% | 95.55% |
| Total Common Equity | 43.98% | 1.96% | -78.09% | -1,587.36% | -251.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.98% | 1.96% | -78.09% | -1,587.36% | -251.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.98% | 1.96% | -78.09% | -1,587.36% | -251.34% |
|
|
|||||